ETRAFON-FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Etrafon-forte patents expire, and when can generic versions of Etrafon-forte launch?
Etrafon-forte is a drug marketed by Schering and is included in one NDA.
The generic ingredient in ETRAFON-FORTE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETRAFON-FORTE?
- What are the global sales for ETRAFON-FORTE?
- What is Average Wholesale Price for ETRAFON-FORTE?
Summary for ETRAFON-FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ETRAFON-FORTE at DailyMed |
US Patents and Regulatory Information for ETRAFON-FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | ETRAFON-FORTE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 014713-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ETRAFON-FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Schering | ETRAFON-FORTE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 014713-006 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
